Match Document Document Title
US20130058969 CHLOROPLASTS ENGINEERED TO EXPRESS PHARMACEUTICAL PROTEINS  
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors and methods for plastid transformation of plants to produce protective antigens and vaccines for...
US20140155322 Method of Preventing Or Reducing Scarring Of Human Skin  
Insulin or a peroxisome proliferator-activated receptor (PPAR) agonist provides reliable and effective prevention of scarring in human skin, or at least a reduction in the severity of scarring....
US20110014247 METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS  
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral...
US20110142800 METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS  
This invention provides compositions comprising a protein, an absorption enhancer, a protease inhibitor, methods for treating diabetes mellitus, comprising administering same, and methods for oral...
US20110097367 MONOLITHIC IN-SITU CROSS-LINKED ALGINATE IMPLANTS  
A method of making and using a monolithic alginate implant is described. The implant is formed by providing an uncrosslinked, highly pure and high molecular weight alginate solution and injecting...
US20140031280 METHODS FOR PREVENTING AND TREATING POST-TRAUMATIC STRESS DISORDER (PTSD)  
Methods for preventing and/or treating symptoms of Post-Traumatic Stress Disorder (PTSD) are provided. The preferred method comprises administration of an effective amount of insulin to the upper...
US20140349926 FORMULATIONS FOR THE TREATMENT OF DIABETES  
Disclosed is a formulation for parenteral administration comprising insulin that comprises a pH memory between 1 to 4 or between 6 to 8 and an aprotic polar solvent, wherein the insulin is...
US20120101033 RETINITIS PIGMENTOSA TREATMENT  
A method of treatment of retinitis pigmentosa using a medically effective dose of insulin, IGF-1, and chlorin e6 topically applied to the conjunctival sac of the afflicted eye. The combination of...
US20130296236 TREATMENT PROTOCOL OF DIABETES TYPE 2  
The present invention refers to a treatment protocol for diabetes type 2 patients.
US20120214736 COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS  
The invention provides compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a gene encoding a Jun N-terminal...
US20140178331 METHOD OF TREATING CEREBRAL HEMORRHAGE AND SUBARACHNOID HEMORRHAGE COMPRISING ADMINISTERING METAL CHELATORS TO THE UPPER ONE-THIRD OF THE NASAL CAVITY  
Methods for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of cerebral hemorrhage and subarachnoid hemorrhage. Therapeutic agents are...
US20140349927 Ladostigil Therapy For Immunomodulation  
Methods for treating individuals suffering from inflammation, specifically systemic inflammation including septic shock and inflammatory conditions affecting the gastrointestinal, myocardial and...
US20110183901 Superior Control of Blood Glucose in Diabetes Treatment  
Methods related to the treatment of diabetes and improving the control of blood glucose levels are provided. In particular, methods are provided for effectively reducing postprandial glucose...
US20130005650 Methods and compositions for treating diseases associated with pathogenic proteins  
Methods and compositions are provided comprising acriflavine for inhibiting and treating diseases and disorders associated with pathogenic proteins causing neurodegenerative diseases and amyloid...
US20130005649 PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON THERAPY TO BASAL INSULIN  
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
US20140342981 HEPATIC INSULIN SENSITIZING SUBSTANCE AND TEST MEAL FOR INSULIN SENSITIZATION  
The present invention provides methods of treating prediabetes, hyperglycemia, type 2 diabetes, AMIS syndrome, and obesity in a subject by administering to the patient HISS. The present invention...
US20110311476 Methods For Treating An Immune Deficiency Or Enhancing Immune Function Using Salicinium, Non-Limited In Terms Of Treatment Indication, But Encompassing Methods For Treating Cancer And Microbial, Bacterial, Viral, Fungal; Non-Limited In Terms of Delivery Mode, Formulation  
The present invention provides novel immunotherapeutic compositions and methods useful for treating or preventing microbial infections, weakened immune systems, diseases in which cells have become...
US20150086616 METHOD FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE  
Oral non-steroidal anti inflammatory drugs (NSAIDs) are not an effective treatment of Alzheimer's disease, because the brain dose is too low. Nasal delivery of NSAIDs such as ibuprofen,...
US20130295074 Pyridoxamine for the Treatment of Diabetic Kidney Disease  
The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, and...
US20130011379 Pyridoxamine for the Treatment of Diabetic Kidney Disease  
The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier, and...
US20120282184 TREATMENT OF OBESITY  
A method for the prevention or treatment of a condition selected from type 2 diabetes, obesity and metabolic syndrome comprising activating a GITRL pathway. Methods for screening for substances to...
US20120269882 Brain Delivery of Insulin to Treat Systemic Inflammation  
Methods and composition for the treatment of systemic inflammation, such as bacterial or viral sepsis, are described. Methods of treating systemic inflammation comprise delivery of insulin to the...
US20120195959 METHOD FOR TREATING DISEASE OR DISORDER OF ADULT CENTRAL NERVOUS SYSTEM ASSOCIATED WITH TISSUE SHRINKAGE OR ATROPHY BY ADMINISTRATION OF INSULIN  
The present invention provides a use of an insulin for manufacture of a medicament for treating or preventing a disorder or disease of a central nervous system of an adult individual, wherein the...
US20110021974 RETINITIS PIGMENTOSA TREATMENT AND PROPHALAXIS  
The invention relates to a method of instilling insulin ophthalmic drops in the conjunctival sac for treating retinitis pigmentosa due to any etiological factors both genetic and non genetic. The...
US20140243261 Method for treating diabetes and fatty liver disese by stimulating cellular metabolism  
The present invention is a method of treating various diseases and conditions through administering a substantial caloric load coupled with administration of hormone to stimulate the body to...
US20120035105 Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments  
The present invention includes a pharmaceutical composition comprising HDV insulin or oral HDV insulin, and one or more additional therapeutic agents useful for the treatment of diabetes and...
US20150196622 MATERIALS AND METHODS FOR MODULATING GLUCOSE UPTAKE  
The subject invention provides materials and methods for modulating cellular glucose uptake. Specifically, in accordance with one embodiment of the subject invention, stem cell factor (SCF) can be...
US20140206611 LONG-ACTING INSULIN FORMULATIONS  
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
US20110301081 LONG-ACTING FORMULATIONS OF INSULINS  
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
US20120070513 Method and Composition for Treating Diabetic Ketoacidosis  
Methods of treating diabetic ketoacidosis are disclosed. The methods utilize an endothelin antagonist to treat diabetic ketoacidosis in mammals, including humans.
US20140206612 ORAL INSULIN THERAPIES AND PROTOCOL  
Methods for treating impaired glucose tolerance and early and late stage diabetes in mammals, for prophylactically sparing β-cell function, aiding in preventing β-cell death, preventing the onset...
US20110144011 Cellular Activation Insulin Therapy  
Diabetic and other patients are treated using an aggressive form of Pulsed Insulin Therapy in which a pre-treatment blood sugar level in the patient of at least 250-300 mg/dL, and the patient is...
US20120148649 COMPOSITION FOR RESTORATION OF AGE RELATED TISSUE IN THE FACE OR SELECTED AREAS OF THE BODY  
A treatment method for restoring of age related tissue loss in the face or selected areas of the body is disclosed which includes injecting an injectable composition containing a growth factor and...
US20150190366 METHODS FOR INHIBITING NEURON APOPTOSIS AND NECROSIS  
The present invention relates generally to methods for inhibiting neuron apoptosis and necrosis associated with excess glutamate release.
US20140294761 TREATMENTS FOR MIGRAINE AND RELATED DISORDERS  
Embodiments are directed to compositions and methods of treating migraine and related neurological disorders. In certain aspects, methods and compositions are for reducing cortical spreading...
US20130252886 METHODS OF DELAYING AND TREATING DIABETES  
The present invention provides methods of treating hyperglycemia and delaying the onset of diabetes, comprising administering to a mammal in need thereof a therapeutically effective amount of a...
US20120157377 METHODS TO ENHANCE NIGHT VISION AND TREATMENT OF NIGHT BLINDNESS  
The invention is for a safe and effective method of administering an opthalmological therapeutic agent for the treatment of night blindness and improving night vision, using insulin, and chlorin...
US20140335170 Reduced Mass Metformin Formulations  
The present invention relates to metformin extended release (XR) formulations with improved compactability to provide reduced mass tablets, granulations, and capsules.
US20120294936 REDUCED MASS METFORMIN FORMULATIONS  
The present invention relates to metformin extended release (XR) formulations with improved compactability to provide reduced mass tablets, granulations, and capsules.
US20140193393 Methods for Treatment of Stroke or Cerebrovascular Accidents Using an ETB Receptor Agonist  
Methods of using an ETB receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ETB receptor agonist is used alone or in combination with a...
US20130125886 METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1  
A method for preventing or reducing adverse effects such as profuse sweating, nausea and vomiting, which normally are associated with subcutaneous and intravenous administration of glucagon-like...
US20130171201 COMPOSITIONS INCLUDING ANTHOCYANIN OR ANTHOCYANIDIN FOR THE PREVENTION OR TREATMENT OF ARTICULAR CARTILAGE-ASSOCIATED CONDITIONS  
Methods of treating an arthritic joint of a subject, including administering a pharmaceutical composition by injection into the arthritic joint, wherein the composition includes an anthocyanin or...
US20150164986 METHOD OF TREATING TYPE I DIABETES USING APOLIPOPROTEIN AIV  
Methods for treating type one diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type one diabetes mellitus are disclosed, including combination...
US20140303077 ALBUMIN FUSION PROTEINS  
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors...
US20140072647 USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL  
The present invention relates to a method for maintaining normoglycemia in a mammal in need thereof, preferably a critically ill patient suffering from acute stress, and to a method for preventing...
US20110275561 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug  
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with...
US20140335074 METHODS FOR IMPROVING MEDICAL THERAPIES  
Methods are provided herein for enhancing the effectiveness of medical therapies by administering agents that suppress a biological damage response that is inducible by the medical therapy...
US20110118178 METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO INSULIN GLARGINE AND METFORMIN  
A method for the treatment of diabetes mellitus type 2 comprising administering (d) desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof,(e) insulin glargine or/and a...
US20150079055 USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE  
An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and...
US20110274758 MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES  
AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense...